Liz Noblin

Liz joined 23andMe in 2017 and is responsible for managing academic collaborations and industry partnerships. Previously, she was a senior scientist at twoXAR, an artificial intelligence-driven drug discovery startup, where she managed science communication and supported academic and industry partnerships. Liz was a postdoctoral fellow at Stanford where she studied cross-talk between epigenetics and metabolism, and earned her PhD in Genetics studying mitochondrial signaling and aging at Yale.